相关实验视频

Updated: Sep 11, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

一个金属代谢纳米调节器重新编程PKM2/HIF-1α/DLAT轴以放大瘤特异性cuproptosis

Xue Zhan¹, Hang Xiao², Xuelian Zhang¹

¹Traditional Chinese Medicine (TCM) Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China; Clinical School of Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.

|August 15, 2025

概括

这项研究介绍了MC@BSA,这是一种破坏癌细胞代谢的纳米药物,可诱导铜诱导的细胞死亡 (cuproptosis). 将其与TEPP-46结合,通过向代谢途径来增强抗瘤作用.

科学领域:

生物医学工程生物医学工程
癌症生物学癌症生物学
代谢途径代谢途径

背景情况:

质亡是一种具有抗瘤潜力的新型细胞死亡途径.
瘤细胞通过代谢补偿抵御cuproptosis.
准铜平衡是触发细胞死亡的关键.

研究的目的:

设计一种纳米药物 (MC@BSA) 来破坏瘤铜平衡.
通过抑制代谢补偿来增强cuproptosis.
研究MC@BSA和PKM2激活剂 (TEPP-46) 的联合治疗效果.

主要方法:

开发一种涂有牛血清白蛋白 (MC@BSA) 的铜纳米复合物.
评估MC@BSA抑制铜流量和诱导反应性氧物种 (ROS) 的能力.
在体外和体内瘤模型中对MC@BSA + TEPP-46复合物的评估.

主要成果:

MC@BSA有效地积聚在瘤中,破坏铜离子平衡并导致线粒体功能障碍.
该MC@BSA + TEPP-46复合体降低了PKM2 / HIF-1α / DLAT轴的下调,从而增强了cuproptosis的敏感性.
在体内研究表明,使用MC@BSA + TEPP-46显著抑制瘤,没有严重的毒性.

结论:

MC@BSA是破坏瘤代谢补偿和诱导cuproptosis的一种有前途的治疗方法.
将MC@BSA与TEPP-46结合起来,通过增强的代谢干扰,增强了抗瘤功效.
该策略通过准代谢脆弱性,为癌症治疗提供了一种新的方法.

关键词:

铜的恒常性是铜的恒常性.金属代谢纳米调节器金属代谢纳米调节器在PKM2/HIF-1α/DLAT轴上瘤特异性的型亡症.cuproptosis 的放大效应

更多相关视频

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...